Subsequent risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after a colposcopic diagnosis of CIN 1 or less


      The purpose of this study was to determine the risk and presentation of cervical intraepithelial neoplasia (CIN) 3 or cancer after colposcopic diagnosis of CIN 1 or less.

      Study design

      After colposcopy for an abnormal cytology, women with CIN 1 or less had annual cytology evaluations and high-risk human papillomavirus (HPV) tests (Hybrid Capture II). Colposcopy was repeated if the cytology result was ASC-H, or worse, ASC-US/high-risk HPV test positive, or every 2 years if the cytology was normal/high-risk HPV test positive. Differences in rates of CIN 3 or cancer were compared by log rank Kaplan-Meier survival analysis.


      With median follow-up periods of 26.3 months, 47 of 2490 women (1.9%) with CIN 1 or less subsequently had CIN 3 or cancer. Subsequent CIN 3 or cancer was more likely if the high-risk HPV test was initially positive (45/1960 women [2.3%]) compared with negative (2/530 women [0.4%]; P = .0002) and if women were older (age ≥30 years, 28/1021 women [2.7%]; age 20-29 years, 17/1017 women [1.7%]; age <20 years, 2/452 women [0.4%]; P = .045). When CIN 3 or cancer was diagnosed, 45 of 46 women (97.8%) had positive high-risk HPV test and 42/46 women (91.3%) had an abnormal cervical cytology. The yield of CIN 3 or cancer per colposcopy for women (4/205 women [2.0%]) who had normal cervical cytology/positive high-risk HPV tests was lower than for women (41/541 women [7.6%]) who had abnormal cervical cytology/positive high-risk HPV tests (chi-square test, 8.3; P < .005), and it did not increase with increasing length of follow-up.


      Annual cytology and high-risk HPV tests with colposcopy for high-risk HPV test positive/abnormal cytology and at least every 2 years for high-risk HPV test positive/normal cytology is advised after a colposcopic diagnosis of CIN 1 or less.

      Key words

      To read this article in full you will need to make a payment

      Purchase one-time access:

      Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online access
      One-time access price info
      • For academic or personal research use, select 'Academic and Personal'
      • For corporate R&D use, select 'Corporate R&D Professionals'


      Subscribe to American Journal of Obstetrics & Gynecology
      Already a print subscriber? Claim online access
      Already an online subscriber? Sign in
      Institutional Access: Sign in to ScienceDirect


        • Buxton E.J.
        • Luesley D.M.
        • Shafi M.I.
        • Rollason M.
        Colposcopically directed punch biopsy: a potentially misleading investigation.
        BJOG. 1991; 98: 1273-1276
        • Chappatte O.A.
        • Byrne D.L.
        • Raju K.S.
        • Nayagam M.
        • Kenney A.
        Histological differences between colposcopic-directed biopsy and loop excision of the transformation zone (LETZ): a cause for concern.
        Gynecol Oncol. 1991; 43: 46-50
        • Pretorius R.G.
        • Zhang W.H.
        • Belinson J.L.
        • Huang M.N.
        • Wu Y.L.
        • Shang X.
        • et al.
        Colposcopically directed biopsy, random cervical biopsy, and endocervical curettage in the diagnosis of cervical intraepithelial neoplasia II or worse.
        Am J Obstet Gynecol. 2004; 191: 430-434
        • ALTS Group
        Results of a randomized trial on the management of cytology interpretations of atypical squamous cells of undermined significance.
        Am J Obstet Gynecol. 2003; 188: 1383-1392
        • Pretorius R.G.
        • Peterson P.
        • Novak S.
        • Azizi F.
        • Sadeghi M.
        • Lorincz A.
        Comparison of two signal-amplification DNA tests for high-risk HPV as an aid to colposcopy.
        J Reprod Med. 2002; 47: 290-296
        • Shingleton H.M.
        • Gore H.
        • Austin J.M.
        • Littleton H.J.
        • Straugin J.M.
        The contribution of endocervical smears to cervical cancer detection.
        Acta Cytol. 1975; 19: 261-264
        • Ismail S.M.
        • Colclough A.B.
        • Dinnen J.S.
        • Eakins D.
        • Evans D.M.
        • Gradwell E.
        • et al.
        Reporting cervical intra-epithelial neoplasia (CIN): Intra- and interpathologist variation and factors associated with disagreement.
        Histopathology. 1990; 16: 371-376
        • Robertson A.J.
        • Anderson J.M.
        • Beck J.S.
        • Burnett R.A.
        • Hawatson S.R.
        • Lee F.D.
        • et al.
        Observer variability in histopathological reporting of cervical biopsy specimens.
        J Clin Pathol. 1989; 42: 231-238
        • Binder M.A.
        • Cates G.W.
        • Emson H.E.
        • Valnicek S.J.
        • Maclachlan T.B.
        • Schmidt E.N.
        • et al.
        The changing concepts of condyloma: a retrospective study of colposcopically directed cervical biopsy.
        Am J Obstet Gynecol. 1985; 151: 213-219
        • Guido R.
        • Solomon D.
        • Burke L.
        Postcolposcopy management strategies for women referred with low-grade intraepithelial lesions or human papillomavirus DNA-positive atypical squamous cells of undetermined significance: a two-year prospective study.
        Am J Obstet Gynecol. 2003; 188: 1401-1405
      1. American College of Obstetricians and Gynecologists. Management of abnormal cervical cytology and histology. ACOG Practice Bulletin no. 66.
        Obstet Gynecol. 2005; 106: 645-664
      2. ALTS Study Group. A randomized trial on the management of low-grade squamous intraepithelial lesion cytology interpretations. Am J Obstet Gynecol 2003;188:1393-400.

        • Peto J.
        • Gilham C.
        • Deacon J.
        • Taylor C.
        • Evans C.
        • Binns W.
        • et al.
        Cervical HPV infection and neoplasia in a large population-based prospective study: the Manchester cohort.
        Br J Cancer. 2004; 91: 942-953
        • Kahn M.J.
        • Castle P.E.
        • Lorincz A.T.
        • Wacholder S.
        • Sherman M.
        • Scott D.R.
        • et al.
        The elevated 10-year risk of cervical precancer and cancer in women with human papillomavirus (HPV) type 16 or 18 and the possible utility of type-specific HPV testing in clinical practice.
        J Natl Cancer Inst. 2005; 97: 1072-1079
        • Nobbenhuis M.A.E.
        • Walboomers J.M.M.
        • Helmerhorst T.J.M.
        • Rozendaal L.
        • Remmink A.
        • Risse E.K.J.
        • et al.
        Relation of human papillomavirus status to cervical lesions and consequences for cervical-cancer screening: a prospective study.
        Lancet. 1999; 354: 2-5
        • Ho G.Y.
        • Bierman R.
        • Beardsley L.
        • Chang C.J.
        • Burk R.D.
        Natural history of cervicovaginal papillomavirus infection in young women.
        N Engl J Med. 1998; 338: 423-428
        • Moscicki A.
        • Shibloski S.
        • Hills N.K.
        • Powell K.J.
        • Jay N.
        • Hanson E.N.
        • et al.
        Regression of low-grade squamous intra-epithelial lesions in young women.
        Lancet. 2004; 356: 1678-1683
      3. American College of Obstetricians and Gynecologists. Evaluation and management of abnormal cervical cytology and histology in the adolescent: ACOG Committee Opinion #330.
        Obstet Gynecol. 2006; 107: 963-968
        • Engelstad L.P.
        • Stewart S.L.
        • Nguyen B.H.
        • Bedeian K.L.
        • Rubin M.M.
        • Pasick R.J.
        • et al.
        Abnormal Pap smear follow-up in a high-risk population.
        Cancer Epidemiol Biomarkers Prev. 2001; 10: 1015-1020
        • Castle P.E.
        • Solomon D.
        • Schiffman M.
        • Wheeler C.
        Human papillomavirus type 16 infections and 2-year absolute risk of cervical precancer in women with equivocal or mild cytologic abnormalities.
        J Natl Cancer Inst. 2005; 97: 1066-1071
        • Cuschieri K.S.
        • Cubie H.A.
        • Waltley M.W.
        • Gilkison G.
        • Arends M.J.
        • Craham C.
        • et al.
        Persistent high risk HPV infection associated with development of cervical neoplasia in a prospective population study.
        J Clin Pathol. 2005; 58: 946-950
        • Belinson J.
        • Qiao Y.L.
        • Pretorius R.G.
        • Zhang W.H.
        • Elson P.
        • Li L.
        • et al.
        Shanxi province cervical cancer screening study: a cross-sectional comparative trial of multiple techniques to detect cervical neoplasia.
        Gynecol Oncol. 2001; 83: 439-444